{"id":13644,"date":"2024-04-17T09:24:24","date_gmt":"2024-04-17T16:24:24","guid":{"rendered":"https:\/\/depts.washington.edu\/diabetes\/?p=13644"},"modified":"2024-04-17T09:24:24","modified_gmt":"2024-04-17T16:24:24","slug":"study-of-t1d-in-adults-provides-new-insights-2-2","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/study-of-t1d-in-adults-provides-new-insights-2-2\/","title":{"rendered":"GLP-1 drug may mitigate Parkinson&#8217;s progression"},"content":{"rendered":"<section class=\"kc-elm kc-css-120325 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-697705 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-573712 kc_text_block\">\n<p class=\"MsoNormal\" style=\"line-height: 18.75pt;\"><span style=\"font-size: 15.3333px;\">A small study published in The New England Journal of Medicine suggests that a GLP-1 receptor agonist similar to the diabetes medication Ozempic and obesity drug Wegovy may lead to modest slowing of Parkinson&#8217;s disease symptoms. Parkinson&#8217;s expert Michael Okun called the findings &#8220;a really encouraging step forward,\" and Hyun Joo Cho of the National Institute of Neurological Disorders and Stroke said the study is important but further research is needed.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"line-height: 18.75pt;\"><span style=\"font-size: 15.3333px;\">\u00a0Full Story: <a href=\"https:\/\/newsletter.smartbrief.com\/uyd\/editProfile.action;jsessionid=F671BCE1AAF9291CD97543F1B6DCEDD2.web2.smartbrief.com?t1=79785395&amp;t2=https%3A%2F%2Fwww.nytimes.com%2F2024%2F04%2F03%2Fhealth%2Fparkinsons-ozempic-glp-1.html\">The New York Times<\/a>\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"link","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-13644","post","type-post","status-publish","format-link","hentry","category-diabetes-related-news","post_format-post-format-link"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=13644"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13644\/revisions"}],"predecessor-version":[{"id":13645,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13644\/revisions\/13645"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=13644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=13644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=13644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}